Gem Hopkins | Head, Investor Relations and Corporate Communications |
Mark Rothera | President and CEO |
Craig Tooman | Chief Financial Officer |
Giles Campion | EVP, Head of R&D and CMO |
Thomas Shrader | BTIG |
Patrick Trucchio | H.C. Wainwright |
Myles Minter | William Blair |
Good day, ladies and gentlemen and welcome to the Silence Therapeutics Interim Results 2021 Conference Call and Webcast. At this time, all participants are in a listen-only mode. Later we will conduct a live question-and-answer session through the phone lines and instructions will follow at that time. Participants can also submit questions through the webinar platform, which will be answered by the company at a later date.
As a reminder, listeners should join the call through either the webcast or the phone lines for the best viewing experience.